Orchid pharma acquisition. Manish Dhanuka, Managing Director and Mr.

• Orchid pharma acquisition “There will be a change in the shareholding pattern of Orchid Pharma pursuant to the scheme, in accordance with the share exchange ratio,” the company said in a filing to the stock exchanges. 50 ORCHID CHEMICALS & PHARMACEUTICALS LIMITED MEMORANDUM OF ASSOCIATION OF ORCHID CHEMICALS & PHARMACEUTICALS LIMITED I. I have a Bachelor of Engineering degree in Mechanical Engineering from VRS College of Engineering and Technology, which gives me a unique perspective and understanding of the technical roles and requirements in 4. , a vertically integrated pharmaceutical company spanning the entire pharmaceutical value chain from discovery to delivery has announced its Q3 financial results for FY 2024-25, reporting a 26% year-on-year increase in Profit After Tax (PAT) in YoY-9 month. Mridul Dhanuka, Whole Time Director are the Director/Member in Otsuka Chemicals (India) Private Limited prior to the acquisition of Orchid Pharma Limited. II. The acquisition of the manufacturing facility in Aurangabad Jul 7, 2014 · Hospira has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd. Manish Dhanuka, Managing Director and Mr. 1 “Board of Directors” or “Board” means the members of the Board of Orchid Pharma Limited. The name of the Company is “ORCHID CHEMICALS & PHARMACEUTICALS LIMITED”. , Bexel Pharmaceuticals Inc. The objects for which the Company is established are: Feb 20, 2025 · Acquisition of the EU GMP certification facilitates Orchid Pharma to service its products to the global key markets and create a healthy international portfolio in perpetuity. and Diakron Pharmaceuticals, Inc. Since the transaction is estimated to be a 2017-18 4333. Orchid Pharma said in a stock-exchange filing a monitoring committee overseeing its resolution plan has decided to extinguish 99% of its share capital and allot zero-coupon debentures Dec 7, 2023 · Following the amalgamation of Dhanuka Laboratories Ltd (DLL) into Orchid Pharma as per the scheme, Orchid Pharma’s post-scheme shareholding will be 74. Dec 20, 2023 · Orchid Pharma has been experiencing a commendable annual growth rate of 15-20%, a testament to its resilience and strategic initiatives in the dynamic pharmaceutical industry. 4 days ago · Orchid Pharma Limited: News, information and stories for Orchid Pharma Limited | NSE India S. Its subsidiaries include Orchid Bio-Pharma Limited, Orchid Pharmaceuticals Inc. Feb 13, 2025 · Orchid Pharma Ltd. Feb 6, 2015 · In 2012, it had announced the acquisition of Orchid Pharma's penicillin and penem active pharmaceutical ingredient (API) business and the API facility at Aurangabad, Maharashtra, along with associated research & development infrastructure in Chennai, through its Indian subsidiary, for about $200 million. Orchid Pharma - Funding, Investments & Acquisitions. among India’s leading pharmaceutical players Vertically integrated with credentials in research, manufacturing and marketing Operations cover the entire pharmaceutical value chain from discovery to delivery Presence across the antibiotic domains spread across oral and sterile categories of more than 20 products Private Limited was the supplier of GCLE for Orchid Pharma Limited. Promoter Stake Sale Dhanuka Laboratories, a key promoter of Orchid Pharma, made headlines by selling 13 lakh equity shares, amounting to a 2. . Dec 16, 2021 · The Board of Directors of Orchid Pharma Limited ("the Company") at its meeting held today, i. 56% stake in the company, at an average price of acquisition of Orchid Pharma Limited. Post acquisition of INR Lakhs Orchid Pharma Limited, this transaction has become a related 2016-17 4693. Nov 29, 2023 · The repercussions of this sale and subsequent acquisition by UTI Mutual Fund reverberated in the stock market, influencing Orchid Pharma’s share prices. The report argues that Orchid is poised for strong growth led by higher capacity utilization, new product launches, and a PLI scheme for a key starting material. 2 “Company” shall mean Orchid Pharma Limited 4. 4. The drug, invented by Indian scientists in 2008, takes a big leap in the global war against bacterial infections. Jul 5, 2014 · US-based injectable drugs major Hospira Inc has completed the acquisition of the Active Pharmaceutical Ingredient (API) manufacturing facility and associated research and development (R&D) facility from Chennai-based Orchid Chemicals and Pharmaceuticals Ltd, almost two years after it first entered into agreement for the acquisition. This entrepreneurial vigor enabled him to take over the operations of Orchid Pharma Ltd. This marks an important milestone. 26, 2023. Below Table Gives all details of Orchid Pharma, including but not limited to its Revenue, Funding information, Investments done, Acquisitions done by Orchid Pharma. 3 “Key Managerial Personnel” means Key Managerial Personnel as defined under sub-section (51) of section 2 of the Companies Act, 2013. Orchid Pharma Limited August 13, 2024 Page 2 of 18 Moderator: Ladies and gentlemen, good day and welcome to the Orchid Pharma Limited Q1 FY25 Earnings Conference Call hosted by Systematix Institutional Equities. Orchid Pharma had experienced high levels of debt since it redeemed its outstanding FCCBs in February 2012. The Registered Office of the Company will be situated in the State of Tamil Nadu. View Gopalsamy Ramesh’s profile on LinkedIn, a professional community of 1 billion members. 45 per cent for the promoter and promoter Mar 30, 2010 · The acquisition includes Orchid's beta-lactam antibiotic formulations manufacturing complex (comprising cephalosporin, penicillin and carbapenem facilities) and pharmaceutical research and Apr 3, 2020 · The monitoring committee of Orchid Pharma Ltd (OPL) has approved the amalgamation of Dhanuka Pharmaceuticals Pvt Ltd (DPPL) into the company, and has issued 10,000 equity shares of OPL with a face value of Rs 10 each to the shareholders of DPPL, towards this end. Details of Directorship & Full Time Positions in Body Mar 24, 2022 · Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Orchid Pharma Investments & Acquisitions (3) Orchid Pharma’s most recent deal was a Early Stage VC with Allecra Therapeutics for . Acquisition of Elder Pharmaceuticals by Torrent Pharmaceuticals Torrent acquired some domestic formulations business of Elder in India and Nepal. : ORCHPHARMA | NSE India S. e. The new promoters have successfully turned around the base business, tripling EBITDA over the past three years. Fuelled by increasing sales and a laser sharp focus on costs, Orchid Pharma reported a 36% surge in total revenue from operations while the EBIDTA has jumped by 104% over the quarter ending September 2021. The report provides revenue and The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by SBICAP Trustee Company Ltd in Orchid Pharma Ltd. As a reminder, all participant lines will be in the listen-only mode and there will be an Feb 20, 2025 · Orchid Pharma Q2 EBIDTA rises 104%, revenue up 36% on increasing sales / -- Orchid Pharma today announced their Q2'22 results. - Mr. where Disposal of 15,385 shares done was reported to the exchange on Dec. 8 There was also a Manufacturing and Supply Agreement present between both the parties where Elder was to exclusively manufacture certain products for Torrent for a duration of three years. 45 party transaction by virtue of Directors becoming related party as stated above. Senior General Manager-Human resources at orchid chemicals and pharmaceuticals ltd · Orchid chemicals&pharmaceuticals ltd · Annamalai University · Chennai · 67 connections on LinkedIn. in March 2020. , December 16, 2021, has considered and approved a draft Scheme of Amalgamation and Arrangement Jul 9, 2014 · The acquisition comes nearly two years after Hospira first rolled out the original agreement, which required $30 million in prior advances. has lost -33. Jul 8, 2014 · Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility-- Purchase enhances cost-competitiveness, paves way for future development -- Feb 27, 2024 · Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. Dec 8, 2023 · Notably, Orchid Pharma board approved a draft scheme of amalgamation with Dhanuka Laboratories Ltd (the promoter of Orchid Pharma) on December 6. Feb 12, 2025 · Orchid Pharma News - Get the Latest Orchid Pharma News, Announcements, Photos & Videos on The Economic Times Stock Quotes: Get all stocks market quotes, company stocks price quotes in India. After years of research that drug has won crucial approvals from the US FDA and European drug regulatory agency. , an Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million. Dhanuka expressed optimism about sustaining this momentum over the next 3-4 years, showcasing the company's commitment to long-term success. Outside of work, he likes to travel for wildlife adventures. Visit Economic Times to read on Indian companies quotes listed on BSE NSE Stock Exchanges & search share prices by market capitalisation Orchid Pharma Ltd. This report initiates coverage on Orchid Pharma, a leading supplier of cephalosporin APIs. III. E. The deal was made on 18-Apr-2013. Mar 7, 2025 · The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in Alathur, Tamil Nadu Copy Link Share on Share on Share on Share on Orchid Pharma Ltd. 23% in the last 1 Month He spearheaded the acquisition of Synmedic Laboratories in the year 2013 which is involved in pharmaceutical formulations. - Post acquisition of Orchid Pharma Limited , this Talent Acquisition Specialist @ Orchid Pharma | HR, Recruiting, Employer Branding · I am a Talent Acquisition Specialist at Orchid Pharma, a leading pharmaceutical company in India. Apr 1, 2020 · Dhanuka Laboratories Ltd has taken over Orchid Pharma Ltd as per an insolvency resolution plan that was approved by courts and the debt-laden company’s lenders. esojo ztcn aalolajr svh mlw mad gfvn smpjqai wdznh jnwmp uvm ybhue qtvy wjbglj rifd